1. Assessment of the Antimicrobial Activity of (Copper Sulphate Pentahydrate and Potash Alum) Nanoparticles on Bacteria (Pseudomonas Aeruginosa) Isolated with Bacterial Urinary Tract Infections (UTIs).
- Author
-
Hussein, Narimann Neamah, Jamil, Taghreed N., Al-hadrawi, Kais Khudhair, Aldhalim, Hanan Khalid, Hameed, Ali Abdulhussein, Mohammed, Kahtan A., and Sharma, Shubham
- Subjects
- *
URINARY tract infections , *COPPER sulfate , *PSEUDOMONAS aeruginosa , *ANTIBACTERIAL agents , *DRUG resistance in bacteria - Abstract
This study examines the impact of nanoparticles of copper sulfate pentahydrate and potash alum on bacteria (Pseudomonas aeruginosa) that were isolated from patients with bacterial urinary tract infections (UTIs). Bacterial urinary tract infections (UTIs) are common infections that occur in both outpatient clinics and nosocomial (hospitalacquired) settings, affecting individuals of all age groups. From a clinical perspective, the differentiation between uncomplicated and complicated urinary tract infections (UTIs) has proven to be advantageous. The coordination between the host's defense mechanisms and bacterial virulence factors plays a crucial role in shaping the progression of an infection. Simple urinary tract infections (UTIs) are typically managed solely with medicines, but complex UTIs necessitate extra treatment to address the underlying factors contributing to the infection. The bacteria, specifically Pseudomonas aeruginosa, were isolated and purified between January and June 2023 using urine samples. The purpose was to assess the effectiveness and inhibitory properties of copper sulfate pentahydrate and potash alum nanoparticles against Pseudomonas aeruginosa. The rapid emergence and widespread dissemination of antibiotic resistance are the primary drawbacks of contemporary antibiotic treatment. Various interventions can be implemented to mitigate this trend. Minimize the administration of antibiotics, maintain accurate dosing, prevent infections, and develop innovative chemical substances for antibiotic compounds. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF